Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution

OBJECTIVE: To characterize associated factors and overall survival of women with metastatic breast cancer treated with trastuzumab after its incorporation into the SUS, and additionally to present the direct costs of this technology. METHODS: This is a retrospective cohort, based on data from comput...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Débora Silva, dos Santos, Arn Migowski Rocha, da Costa, Susanne Crocamo Ventilari, da Costa, Rodrigo Saar, Senna, Katia Marie Simões e, Zimmermann, Ivan Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Saúde Coletiva 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642446/
https://www.ncbi.nlm.nih.gov/pubmed/37878833
http://dx.doi.org/10.1590/1980-549720230045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642446/
https://www.ncbi.nlm.nih.gov/pubmed/37878833
http://dx.doi.org/10.1590/1980-549720230045

Ejemplares similares